TAIKO PHARMACEUTICAL CO.,LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 351 JPY | -0.28% |
|
+5.72% | +15.84% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
TAIKO PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company. The Company is engaged in three business segments. The Pharmaceutical Product segment is engaged in the manufacturing, sales and export of gastrointestinal drugs under the name SEIROGAN, SEIROGAN TOI-A (sugar coated tablet) and PISHUT. The Infection Control segment is engaged in the planning, development and sales of infection control products, which apply proprietary technique regarding chlorine dioxide gas. The Others segment is engaged in the manufacturing and sales of bath liquid, soap and gardening pyroligneous acid.
Sector
Pharmaceuticals
Calendar
2024-05-09
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +15.84% | 112M | |
| +19.27% | 43.18B | |
| +24.05% | 23.23B | |
| +15.11% | 14.6B | |
| +38.36% | 11.5B | |
| -7.63% | 6.79B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +10.21% | 5.31B | |
| -2.27% | 4.81B |
- Stock Market
- Equities
- 4574 Stock
- News Taiko Pharmaceutical Co.,Ltd.
- Taiko Pharmaceutical to Pay 607 Million Yen Penalty; Shares Down 3%
